ArticleTransboundary and emerging diseases2023
A Modified Recombinant DNA-Based SARS-CoV-2 Vaccine Expressing Stabilized Uncleavable Spike Protein Elicits Humoral and Cellular Immunity against Various SARS-CoV-2 Variants of Concern.
Rwaa H Abdulal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.